ライフサイエンスコーパス: respiratory symptom

1 ratory infections, and from infants with any respiratory symptom.

2 ive days with one major symptom plus another respiratory symptom.

3 Five exposed individuals developed respiratory symptoms.

4 rolled within 4 days of acute onset of upper respiratory symptoms.

5 uggests that pesticide use may contribute to respiratory symptoms.

6 ional small airway abnormality regardless of respiratory symptoms.

7 an sensory nerves, which are responsible for respiratory symptoms.

8 orticosteroids in patients with non-specific respiratory symptoms.

9 sinusitis who presents with persistent upper respiratory symptoms.

10 natural protection conferred by GAS against respiratory symptoms.

11 al needs to release infectious particles via respiratory symptoms.

12 roteins was associated with longer time with respiratory symptoms.

13 pet albumins was associated with more severe respiratory symptoms.

14 fter correction for age, antibiotic use, and respiratory symptoms.

15 ing medical treatment, and with diarrhea and respiratory symptoms.

16 inated environments are at increased risk of respiratory symptoms.

17 smokers who do not meet this definition have respiratory symptoms.

18 ons of patients with asthma cause only upper respiratory symptoms.

19 NP FARP) is performed for many patients with respiratory symptoms.

20 ncidence, and duration and severity of upper respiratory symptoms.

21 accination but reduced the duration of upper respiratory symptoms.

22 of mandatory influenza testing for HCWs with respiratory symptoms.

23 status, H influenzae was not associated with respiratory symptoms.

24 specific prodromal illness before developing respiratory symptoms.

25 rong evidence of protection against atypical respiratory symptoms.

26 infected people with a history of smoking or respiratory symptoms.

27 (BHR) can be present in subjects without any respiratory symptoms.

28 n HIV-positive and HIV-negative persons with respiratory symptoms.

29 eted spirometry and questionnaires assessing respiratory symptoms.

30 doctor diagnosed hay fever or allergic upper respiratory symptoms.

31 significant effect on the protection against respiratory symptoms.

32 e recently been found in children with upper respiratory symptoms.

33 ital capacity (FEV1:FVC) less than 0.70 with respiratory symptoms.

34 esenting non-severe (n=71) and severe (n=44) respiratory symptoms.

35 oids, or unscheduled clinical evaluation for respiratory symptoms.

36 s from SARS-CoV-2 PCR-negative patients with respiratory symptoms.

37 bacco smoke or e-cigarettes despite negative respiratory symptoms.

38 Of the 23 cases, 20 (87%) had respiratory symptoms.

39 .64), compared with those without disease or respiratory symptoms.

40 All neonatal case-patients had respiratory symptoms.

41 ely treated with ivacaftor in the absence of respiratory symptoms.

42 ded participant-reported treatment usage and respiratory symptoms.

43 involvement (25.0% vs 46.2%), and absence of respiratory symptoms (0% vs 23.1%).

44 patients with anosmia show no or only minor respiratory symptoms(1).

45 were syncope or presyncope (37.4% of cases), respiratory symptoms (12.1%), and nausea or vomiting (9.

46 13.9% (n = 41) were reactions with respiratory symptoms, 25.4% (n = 75) with cardiovascular

47 (86 [16.0%]), and acute onset of significant respiratory symptoms (299 [55.6%]).

48 IMD-W cases presented more often with respiratory symptoms (45%, P < .001); 16% of IMD-W patie

49 .2% of patients), depression/apathy (71.4%), respiratory symptoms (66.7%) and weight loss (49.2%).

50 The majority of patients presented with respiratory symptoms (97%), gastrointestinal symptoms (7

51 His first respiratory symptom, a dry cough, developed on DOI 10.

52 The burden of chronic respiratory symptoms, abnormal spirometry, and air pollu

53 rhea and cramps, with 2.6% of users querying respiratory symptoms after the procedure, including coug

54 Children less frequently reported lower respiratory symptoms (age <18: 21%, age 18-49: 60%, age

55 In 950 individuals who presented with any respiratory symptom among a population-based cohort of 2

56 andard spirometry, internationally validated respiratory symptom and exposure questionnaires, and an

57 ory of tuberculosis and, among them, 16% had respiratory symptoms and 41% X-ray abnormalities.

58 9 subjects (46 with asthma) with acute upper respiratory symptoms and after symptomatic resolution.

59 out asthma, individuals with asthma had more respiratory symptoms and airflow limitation and higher l

60 cterize microbial exposure as a predictor of respiratory symptoms and allergies.

61 sal mucus samples were analyzed for RVs, and respiratory symptoms and asthma exacerbations were recor

62 d epidemiologic evidence links exposure with respiratory symptoms and asthma exacerbations.

63 er an allergic phenotype was associated with respiratory symptoms and exacerbations.

64 DAP concentrations with repeated measures of respiratory symptoms and exercise-induced coughing at 5

65 , and DM concentrations were associated with respiratory symptoms and exercise-induced coughing in th

66 Respiratory symptoms and fever were common (60% vaccinee

67 or antibiotic treatment, prolonged prodromal respiratory symptoms and fever, and extrapulmonary (skin

68 or antibiotic treatment, prolonged prodromal respiratory symptoms and fever, and extrapulmonary (skin

69 presented to our emergency departments with respiratory symptoms and had a respiratory viral panel (

70 hether early term-born children have greater respiratory symptoms and health care use in childhood co

71 he association of chronic liver disease with respiratory symptoms and hypoxia is well recognized.

72 iratory viruses and bacteria trigger similar respiratory symptoms and it is possible that the importa

73 ll transplant candidates and recipients with respiratory symptoms and LRT and URT RV testing via mult

74 ry of tuberculosis was a strong predictor of respiratory symptoms and lung abnormalities, before olde

75 To assess and characterize respiratory symptoms and lung function in professional c

76 imated associations between HAP exposure and respiratory symptoms and lung function in young, nonsmok

77 us disease 2019 (COVID-19), manifesting with respiratory symptoms and multi-organ dysfunction.

78 ssociation between EDCs exposure and asthma, respiratory symptoms and obesity in schoolchildren.

79 r exposure may influence the risk of asthma, respiratory symptoms and obesity.

80 Patients recorded daily worsening of respiratory symptoms and peak expiratory flow (PEF), and

81 obstructive respiratory diseases, rhinitis, respiratory symptoms and possible determinants of diseas

82 isease (COPD) is characterized by persistent respiratory symptoms and progressive airflow obstruction

83 .5) and NO(2), was associated with increased respiratory symptoms and risk of COPD exacerbation.

84 ergic phenotype is associated with increased respiratory symptoms and risk of COPD exacerbations.

85 uals with early COPD more often have chronic respiratory symptoms and severe lung function impairment

86 Respiratory symptoms and shedding of challenge virus wer

87 e definition that combines acute (<=14 days) respiratory symptoms and signs and general danger signs

88 -weighted population prevalence estimates of respiratory symptoms and spirometric abnormalities were

89 ed 620 high allergy-risk children, recording respiratory symptoms and spirometry at 12 and 18 years.

90 oximity to elemental sulfur applications and respiratory symptoms and spirometry of children living i

91 l children in relation to reported time with respiratory symptoms and the presence of different RV sp

92 dren and adults-is characterised by variable respiratory symptoms and variable airflow limitation.

93 ients with CO-RADS 4-5 presented without any respiratory symptoms and were diagnosed with COVID-19.

94 investigate whether mugwort LTP could elicit respiratory symptoms and whether a primary food LTP alle

95 ndergoing diagnostic bronchoscopy because of respiratory symptoms and/or suspected IFD between 2009 a

96 on in severe exacerbations and ED visits for respiratory symptoms) and safety.

97 ncluding interviews at 6, 12, and 18 months (respiratory symptoms) and spirometry and CO (ppm) in exh

98 ts aged 12-65 years with fever, at least one respiratory symptom, and one constitutional symptom of i

99 All cases had fever; 12 (92%) had respiratory symptoms, and 3 (23%) were hospitalized for

100 Six of 9 infected subjects had respiratory symptoms, and 3 had headache after inoculati

101 with constitutional symptoms, 59 (98%) with respiratory symptoms, and 54 (90%) with gastrointestinal

102 e nsLTPs, respectively) were associated with respiratory symptoms, and a correlation was observed bet

103 tcomes included inflammatory markers in BAL, respiratory symptoms, and admissions for exacerbations.M

104 unction, change in lung function (12-18 yr), respiratory symptoms, and asthma.

105 Fever, respiratory symptoms, and dyspnea were the most frequent

106 us significantly reduced fever, weight loss, respiratory symptoms, and infectious load.

107 Patients exhibited generally mild respiratory symptoms, and no patient required ventilator

108 m scores including heartburn, regurgitation, respiratory symptoms, and pain scores remained constant

109 ted the changes in the prevalence of asthma, respiratory symptoms, and risk factors between 2008 and

110 n the first parental report of wheeze, other respiratory symptoms, and/or use of asthma rescue/contro

111 criteria (fever, history of fever, or severe respiratory symptoms [apnea, stridor, nasal flaring, whe

112 Respiratory symptoms appeared before skin symptoms.

113 Chronic non-specific respiratory symptoms are difficult to manage.

114 Chronic respiratory symptoms are more common than would be antic

115 Increased respiratory symptoms are reported, but limited data exis

116 Adults with respiratory symptoms are the target population.

117 sease could reduce the prevalence of chronic respiratory symptoms as much as eliminating smoking.

118 selected community controls, with or without respiratory symptoms, as long as they do not meet the cr

119 low, and 16 of 21 studies reported increased respiratory symptoms associated with Asian dust exposure

120 Mothers reported their child's respiratory symptoms at 5 and 7 years of age.

121 Factors associated with respiratory symptoms at 5 years among MP were respirator

122 Among 4200 adults who presented with acute respiratory symptoms at a variety of medical practice se

123 Seventy-five (21.8%) had respiratory symptoms at birth, and 34 (10.0%) required n

124 .67-0.85) was associated with a low risk for respiratory symptoms at birth.

125 severe breathing difficulties, and nocturnal respiratory symptoms at home within 2 weeks (all P < .05

126 Factors associated with respiratory symptoms at school age are early respiratory

127 dence interval [CI], 1.51 to 6.66; P=0.002), respiratory symptoms at the time of CT and BAL (odds rat

128 l as illness that was specifically caused by respiratory symptoms (B: 1.45; 95% CI: 1.21, 1.70), wher

129 All PM exposures were associated with respiratory symptoms based on single-pollutant models, w

130 increases in emergency department visits for respiratory symptoms (beta = -4.03 [95% CI, -13.76 to 5.

131 ns (p=0.03) were associated with presence of respiratory symptoms but BoV plasma detection was not.

132 Pla a 2 reactivity was associated with respiratory symptoms but inversely related to systemic r

133 HCWs with respiratory symptoms but no fever may pose a risk of inf

134 our hospital, an influenza-positive HCW with respiratory symptoms but no fever was linked to a case o

135 e participants were aged 18-65 years, had no respiratory symptoms compatible with asthma or chronic o

136 xposure to OP pesticides was associated with respiratory symptoms consistent with possible asthma in

137 pneumonia (CAAP; "cases") and those without respiratory symptoms ("controls"), who were enrolled in

138 re diagnosis of conditions that present with respiratory symptoms (COPD, heart failure, asthma) and d

139 fore diagnosis of conditions presenting with respiratory symptoms (COPD, heart failure, asthma), and

140 Chronic respiratory symptoms (cough and phlegm lasting >2 weeks)

141 Respiratory symptoms (cough, phlegm, wheeze, or chest ti

142 After excluding three subjects whose respiratory symptoms could be attributed to other condit

143 tive patients showed more-frequent preceding respiratory symptoms, cranial nerve involvement, and a b

144 aused by respiratory problems, prevalence of respiratory symptoms determined by ISAAC Questionnaires,

145 Questionnaires, and factors associated with respiratory symptoms determined by univariate and multiv

146 se patients completed the monitoring period; respiratory symptoms developed in 28 of them (1%); all t

147 to study whether the incidence of asthma and respiratory symptoms differ by menopausal status in a lo

148 Urinary arsenic was related specifically to respiratory symptoms (difficulty breathing, wheezing, an

149 d to the emergency department with fever and respiratory symptoms during 2009-2013.

150 aseline platelet activation and milder upper respiratory symptoms during aspirin-induced reactions, P

151 rket bakeries, who had declared work-related respiratory symptoms during routine health surveillance.

152 s (P < .05) and time to recovery after first respiratory symptoms during the first year of life (P <

153 of early postnatal eNO levels and subsequent respiratory symptoms during the first year of life.

154 There is little knowledge of variations in respiratory symptoms during the menstrual cycle in a gen

155 ere were also increases in the prevalence of respiratory symptoms during the same period.

156 The participants who reported fewer respiratory symptoms (dyspnoea and night-time awakenings

157 ure, heart rate, body weight, lung function, respiratory symptoms, exhaled breath nitric oxide [eNO],

158 Current respiratory symptoms, exposure to biomass, and ever-smok

159 hrough 28 February 2014, we tested HCWs with respiratory symptoms for influenza and other respiratory

160 ted in lung tissue samples from workers with respiratory symptoms found to have lymphocytic bronchiol

161 ted with reduced lung function and increased respiratory symptom frequency, suggesting a role in the

162 Adults hospitalized with respiratory symptoms from severe acute respiratory syndr

163 entation including cardiovascular and severe respiratory symptoms (grade IV-V vs I-III in Cox scale).

164 ns (ie gastrointestinal, dermatological, and respiratory symptoms), growth, tolerance acquisition to

165 e >5 years (AUC = 0.77), prodromal fever and respiratory symptoms >6 days (AUC = 0.79), and PCT <0.25

166 age >5 years (AUC=0.77), prodromal fever and respiratory symptoms >6 days (AUC=0.79), and PCT <0.25 m

167 ation between IgE sensitization and allergic respiratory symptoms has usually been evaluated by dicho

168 italized patients with COVID-19 experiencing respiratory symptoms have different complications (infla

169 However, in elite sport, respiratory symptoms have poor diagnostic value.

170 enting with ARI, compared with those without respiratory symptoms (ie, asymptomatic individuals) or h

171 Thus, the respiratory symptoms improved by the use of NPPV in chil

172 adults (those who do not recognize or report respiratory symptoms) improves health outcomes.

173 coabdominal compression technique before any respiratory symptoms in 1-month-old neonates from the Co

174 ociations between air pollution exposure and respiratory symptoms in adults has generally been inconc

175 There were moderate increases in asthma and respiratory symptoms in adults in western Sweden between

176 ly higher in nasal lavage fluid during acute respiratory symptoms in all subjects (2.9% vs 1.0%, n =

177 Selective NSAID exposure caused respiratory symptoms in approximately 1 in 13 patients w

178 d identifies lung function decline and extra-respiratory symptoms in aspirin-exacerbated respiratory

179 ections, host and environmental factors, and respiratory symptoms in children.

180 Exacerbations of respiratory symptoms in chronic obstructive pulmonary di

181 Increased rates of respiratory symptoms in early term-born children persist

182 immune response to influenza vaccination and respiratory symptoms in healthy adults.

183 rhinovirus infection, we observed increased respiratory symptoms in healthy and asthmatic subjects w

184 air pollution was associated with increased respiratory symptoms in healthy infants.

185 d inflammation processes in porcine airways, respiratory symptoms in humans were rare and less severe

186 and data regarding the onset of fever and/or respiratory symptoms in infants, healthcare seeking, hos

187 tigators may choose to exclude controls with respiratory symptoms in light of epidemiologic principle

188 Evaluation of new respiratory symptoms in military personnel after service

189 o peach leaves was the cause of occupational respiratory symptoms in our patients.

190 to estimate the prevalence of NSAID-induced respiratory symptoms in population across Europe and to

191 the first day of their last menstruation and respiratory symptoms in the last 3 days.

192 ly DE, were nonsignificantly associated with respiratory symptoms in the previous 12 months at 5 or 7

193 Undiagnosed asthma was defined as multiple respiratory symptoms in the previous 12 months without a

194 and records of medication use and asthma and respiratory symptoms in the previous 3 days.

195 modeling showed a shorter duration of upper respiratory symptoms in the probiotic group than in the

196 non-specific fever (in 1607 [23%] patients), respiratory symptoms (in 1197 [17%] patients), hand, foo

197 Although respiratory symptoms, including wheezing, are common in

198 hat airway inflammation and the frequency of respiratory symptoms increase, whereas lung function dec

199 Specifically, asthma medication usage and respiratory symptoms increased [OR=3.51; 95% confidence

200 The risk of respiratory symptoms increased in early postmenopausal (

201 New-onset asthma and respiratory symptoms increased in women becoming postmen

202 ould attenuate the severity of sinonasal and respiratory symptoms induced during aspirin challenge in

203 tions between serum MMP-7 and lung function, respiratory symptoms, interstitial lung abnormalities (I

204 Prediction of asthma in young children with respiratory symptoms is hampered by the lack of objectiv

205 s were frequently asymptomatic (39%) and had respiratory symptoms less often than younger children (2

206 ADMA was associated with less IgE, increased respiratory symptoms, lower lung volumes, and worse asth

207 We examined respiratory symptoms, lung function, and levels of infla

208 All subjects were monitored for respiratory symptoms, lung function, and nasal viral loa

209 Although adults with respiratory symptoms may be an initial target population

210 Onset of respiratory symptoms may be misdiagnosed as infection.

211 This suggests onset of respiratory symptoms may be misdiagnosed as infection.

212 ient-reported quality of life with regard to respiratory symptoms; minimum clinically important diffe

213 milarly associated with airflow obstruction, respiratory symptoms, more emphysema, and gas trapping i

214 arkinsonism, depression/apathy, weight loss, respiratory symptoms, mutations in the DCTN1 gene and TA

215 sdiagnosed asthma (n = 23), and no asthma or respiratory symptoms (n = 27).

216 B participants were those who presented with respiratory symptoms, negative TB tests and resolution o

217 B participants were those who presented with respiratory symptoms, negative TB tests, and resolution

218 ction (ARI; defined as the presence of >/= 2 respiratory symptoms not meeting ILI criteria) and influ

219 temic food-induced reactions, but lower past respiratory symptoms occurrence.

220 95% confidence interval [CI], 1.88 to 6.03), respiratory symptoms (odds ratio, 2.13; 95% CI, 1.48 to

221 , and sore throat were the three most common respiratory symptoms of HAdV infections.

222 of 6,425 never-smoking participants without respiratory symptoms or disease were modeled as a functi

223 ty-dwelling adults sampled without regard to respiratory symptoms or disease.

224 SpO(2) in triplicate in children who had no respiratory symptoms or signs in the past 2 weeks.

225 ren, nasopharyngeal viral infection (without respiratory symptoms or signs) in 11.9%, malaria in 10.5

226 ution exposures were associated with chronic respiratory symptoms or spirometric abnormalities and no

227 ory of tuberculosis having increased risk of respiratory symptoms (OR, 4.02; 95% confidence interval

228 nded reactions (coexistence of cutaneous and respiratory symptoms) or food-dependent NSAID-induced an

229 medical emergencies were related to syncope, respiratory symptoms, or gastrointestinal symptoms, and

230 n to those who were healthy or those without respiratory symptoms: OR 3.05 (95% confidence interval [

231 exposure affects the risk of infections and respiratory symptoms over the first year of life.

232 ng episode (P = .048) and in fewer days with respiratory symptoms over the subsequent year in compari

233 cus was inversely associated with subsequent respiratory symptoms (P < .05) and time to recovery afte

234 RV-C were significantly associated with more respiratory symptoms (p = 0.03, p = 0.007).

235 ficant association between air pollution and respiratory symptoms, particularly in the week after res

236 sis are not uncommon and are associated with respiratory symptoms, physical examination abnormalities

237 onnaire regarding obstructive lung diseases, respiratory symptoms, potential risk factors, and also q

238 r the relationship between air pollution and respiratory symptom prevalence differed between individu

239 was associated with worse lung function and respiratory symptoms prior to ART initiation, and nearly

240 7 years), no underlying disease, family with respiratory symptoms, prior antibiotic treatment, prolon

241 7 years), no underlying disease, family with respiratory symptoms, prior antibiotic treatment, prolon

242 argue that selecting controls regardless of respiratory symptoms provides the least biased estimates

243 ing logistic (asthma) and negative binomial (respiratory symptoms) regressions, adjusting for age, bo

244 We report the study of 37 workers with respiratory symptoms related to occupational exposure to

245 in those without established COPD) as acute respiratory symptoms requiring either antibiotics or sys

246 iving area were associated with increases in respiratory symptoms, rescue medication use, and risk of

247 Three patients had severe respiratory symptoms resistant to systemic steroids, and

248 His respiratory symptoms resolved but the diarrhea persisted

249 ome residence, comorbid conditions, obesity, respiratory symptoms, respiratory rate, fever, absolute

250 No significant difference in respiratory symptoms (risk difference, -0.01; 95% CI, -0

251 Internet search queries for respiratory symptoms rose approximately one week after q

252 Respiratory symptoms rose significantly at days 7-10 aft

253 ary endpoint (Quality of Life-Bronchiectasis-Respiratory Symptoms Score at Week 4) in favor of aztreo

254 from baseline Quality of Life-Bronchiectasis Respiratory Symptoms scores (QOL-B-RSS) at 4 weeks.

255 ication, having asthma attacks, or both) and respiratory symptoms scores were analyzed by using logis

256 duals with early COPD more often had chronic respiratory symptoms, severe lung function impairment, a

257 d exploratory outcomes (gastrointestinal and respiratory symptoms, severity of gastrointestinal and r

258 ieve individuals who acutely wheeze and have respiratory symptoms should be managed with a beta agoni

259 manifestations of COVID-19 are dominated by respiratory symptoms, some patients present other severe

260 We assessed chronic respiratory symptoms, spirometric abnormalities, and per

261 The prevalence of chronic respiratory symptoms, spirometric obstruction, and restr

262 of airway inflammation and seems to precede respiratory symptoms, such as asthma, in childhood.

263 ght of differences in inhaled antibiotic and respiratory symptoms, suggesting that the pathways repre

264 daily scores on the 21-item Wisconsin Upper Respiratory Symptom Survey.

265 and April 2020 with moderate to severe upper respiratory symptoms suspicious for COVID-19.

266 Spirometry, respiratory symptom tests, and flow cytometry were perfo

267 MP have more respiratory symptoms than FT during early childhood.

268 e coronavirus 2 (SARS-CoV-2) virus, leads to respiratory symptoms that can be fatal.

269 ion can underpin and account for a number of respiratory symptoms that otherwise appear incongruous w

270 us dynamics, particle release in relation to respiratory symptoms, the amount of virus shed and, impo

271 ter confirming that there was no wheezing or respiratory symptoms, the lung sound spectrums of the in

272 s from working, but allow afebrile HCWs with respiratory symptoms to have contact with patients.

273 cs model fitted to virological, systemic and respiratory symptoms to investigate how within-host dyna

274 nical practice in patients with non-specific respiratory symptoms to predict response to inhaled cort

275 Presentation ranged from mild upper respiratory symptoms to respiratory failure.

276 ata on spirometry, bronchial responsiveness, respiratory symptoms, total and allergen-specific IgE an

277 he resolution of symptoms (P < .01 for upper respiratory symptom tract scores and P < .001 for LRTS s

278 rols who had never smoked and measured their respiratory symptoms using the COPD Assessment Test (CAT

279 Respiratory symptoms varied significantly during the men

280 Upper respiratory symptoms were also more frequently reported

281 Cases without respiratory symptoms were analyzed to calculate the prop

282 exercise-related symptoms, BHR symptoms, and respiratory symptoms were assessed with the Asthma Contr

283 Chronic respiratory symptoms were associated with current/ex-smo

284 s) PD cases and when PD cases with prominent respiratory symptoms were compared with controls.

285 ld be identified on HRCT of the lungs and no respiratory symptoms were consistently reported in the E

286 s suspected of having COVID-19 infection and respiratory symptoms were enrolled.

287 Increasing age and respiratory symptoms were indicators of infectivity of N

288 Respondents reporting relevant respiratory symptoms were invited for post-bronchodilato

289 Respiratory symptoms were present in 50% of current or f

290 Medication usage and respiratory symptoms were recorded by questionnaire.

291 Eight hundred patients admitted with respiratory symptoms were tested by a 12-virus respirato

292 Adults develop respiratory symptoms, which can progress to acute respir

293 we enrolled adult ED patients with fever or respiratory symptoms who met criteria for antiviral trea

294 on was detected among those individuals with respiratory symptoms who underwent diagnostic testing, i

295 We conclude that exclusion of controls with respiratory symptoms will result in biased estimates of

296 These relations link respiratory symptoms with hormonal changes through the m

297 andardized evaluation for deployment-related respiratory symptoms within 6 months of returning to the

298 speculate about different endotypes inducing respiratory symptoms within athletes.

299 ne hospital admission due to exacerbation of respiratory symptoms within the preceding year.

300 alth care professional due to concerns about respiratory symptoms, within 72 hours of discharge in in